Our mission
AMA aims to become a global leader in producing stable isotopes, addressing critical market needs and expanding their potential uses. Initiatives include:
Production of stable isotopes
AMA will start producing C13 isotopes, with ongoing negotiations with major consumers willing to commit to purchasing the entire annual production capacity of 1000 kg per year.
Local research centre
Creating a research centre dedicated to developing isotopic compounds from stable isotopes, primarily for the medical sector.
Vertical integration of pharmaceutical production
Starting with isotopes produced at Seruci, Italy, will be a key hub for producing non-radioactive isotopes.
Cost-effective solutions
Enabling large-scale production of stable isotopes at reduced costs, opening new usage opportunities in emerging sectors like cosmetics, nutrition, and other innovative applications.
European leadership
Gonnesa—Seruci and Nuraxi Figus will transform into the European hub for stable isotope production, creating a centre of excellence in Europe.
The investment concerns an area that has suffered the consequences of mining closure. It has significantly impacted the territory, and AMA can boast solid support from local and national authorities for the project’s realization.